EPS group EP-PharmaLine Co.,Ltd.

NEWS

  • December 18, 2023 Notice of Change in Executive Structure This is to inform you of the change in the executive structure.
  • October 2, 2023 EP-PharmaLine is a proud recipient of Contact Center Awards 2023 "Jury‘s Special Award". EP-PharmaLine received the Jury‘s Special Award at the Contact Center Awards 2023, hosted by Rick Telecom Co., Ltd. and the editorial department of Call Center Japan.
    Awards
  • August 1, 2023 EP-PharmaLine Named One of the Top Pharma Consulting Company in Japan 2023 EP-PharmaLine Company has been named one of the "Top Pharma Consulting Company in Japan 2023" by Pharma Tech Outlook APAC.
    The article provides the overview of EP-PharmaLine, its business initiatives and achievements.
    Awards
    EP-PharmaLine | Top Pharma Consulting Company in Japan-2023 (pharmatechoutlook.com)
  • October 25,2022 Notice of Change in Parent Company This is to inform you of the change in the Parent Company.
  • May 27,2021 Notice from EPS Holdings Notice Regarding Agreement with SUZUKEN Co., Ltd. for Equity Participation in EP-PharmaLine
  • June 1,2020 Notice of Split of CMR Business and Succession of Business by EP-Force Co., Ltd. On June 1, 2020, EP-PharmaLine Co., Ltd. and EP-Force Co., Ltd. split off the CMR business of EP-PharmaLine Co., Ltd. and EP-Force Co., Ltd. took over the CMR business for the purpose of further business development
    COMPANY DATA EP-Force Co., Ltd. (epforce.co.jp)
  • May 14,2020 Introducing the COVID-19 Contact Center Services Launched contact center and mental health consultation center related to COVID-19
  • May 12,2020 Notice of Company Split and Business Succession The CMR business of EP-PharmaLine Co., Ltd. was split off on June 1, 2020 and EP-Force Co., Ltd. took over the CMR business.
  • April 15,2020 Notice Concerning Reorganization of Subsidiary of our company From June 1, 2020 (planned), the Company has decided to transfer EP-PharmaLine's MR outsourcing business to EP-Force through an absorption-type company split.